Literature DB >> 21185184

Molecular probes for the A2A adenosine receptor based on a pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine scaffold.

T Santhosh Kumar1, Shilpi Mishra, Francesca Deflorian, Lena S Yoo, Khai Phan, Miklos Kecskés, Angela Szabo, Bidhan Shinkre, Zhan-Guo Gao, William Trenkle, Kenneth A Jacobson.   

Abstract

Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine derivatives such as SCH 442416 display high affinity and selectivity as antagonists for the human A(2A) adenosine receptor (AR). We extended ether-linked chain substituents at the p-position of the phenyl group using optimized O-alkylation. The conjugates included an ester, carboxylic acid and amines (for amide condensation), an alkyne (for click chemistry), a fluoropropyl group (for (18)F incorporation), and fluorophore reporter groups (e.g., BODIPY conjugate 14, K(i) 15 nM). The potent and A(2A)AR-selective N-aminoethylacetamide 7 and N-[2-(2-aminoethyl)-aminoethyl]acetamide 8 congeners were coupled to polyamidoamine (PAMAM) G3.5 dendrimers, and the multivalent conjugates displayed high A(2A)AR affinity. Theoretical docking of an AlexaFluor conjugate to the receptor X-ray structure highlighted the key interactions between the heterocyclic core and the binding pocket of the A(2A)AR as well as the distal anchoring of the fluorophore. In conclusion, we have synthesized a family of high affinity functionalized congeners as pharmacological probes for studying the A(2A)AR. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185184      PMCID: PMC3081901          DOI: 10.1016/j.bmcl.2010.11.082

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  24 in total

1.  An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers.

Authors:  David J Brooks; Spyridon Papapetropoulos; Francois Vandenhende; Davorka Tomic; Ping He; Alex Coppell; Gilmore O'Neill
Journal:  Clin Neuropharmacol       Date:  2010 Mar-Apr       Impact factor: 1.592

Review 2.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

3.  BODIPY dyes and their derivatives: syntheses and spectroscopic properties.

Authors:  Aurore Loudet; Kevin Burgess
Journal:  Chem Rev       Date:  2007-10-09       Impact factor: 60.622

4.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

5.  GPCR ligand-dendrimer (GLiDe) conjugates: future smart drugs?

Authors:  Kenneth A Jacobson
Journal:  Trends Pharmacol Sci       Date:  2010-10-18       Impact factor: 14.819

6.  "Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.

Authors:  Melissa Perreira; Jian-Kang Jiang; Athena M Klutz; Zhan-Guo Gao; Asher Shainberg; Changrui Lu; Craig J Thomas; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

7.  125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.

Authors:  M E Olah; C Gallo-Rodriguez; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

8.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

9.  Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).

Authors:  Peter A LeWitt; M Guttman; James W Tetrud; Paul J Tuite; Akihisa Mori; Philip Chaikin; Neil M Sussman
Journal:  Ann Neurol       Date:  2008-03       Impact factor: 10.422

10.  Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor knockout mice with microarray profiling.

Authors:  Liqun Yu; Joana E Coelho; Xiaoling Zhang; Yutao Fu; Abigail Tillman; Ulas Karaoz; Bertil B Fredholm; Zhiping Weng; Jiang-Fan Chen
Journal:  Physiol Genomics       Date:  2009-03-03       Impact factor: 3.107

View more
  11 in total

1.  Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms.

Authors:  Jesse Lea Carlin; Shalini Jain; Elizabeth Gizewski; Tina C Wan; Dilip K Tosh; Cuiying Xiao; John A Auchampach; Kenneth A Jacobson; Oksana Gavrilova; Marc L Reitman
Journal:  Neuropharmacology       Date:  2016-11-30       Impact factor: 5.250

2.  Photoaffinity Labeling of the Human A2A Adenosine Receptor and Cross-link Position Analysis by Mass Spectrometry.

Authors:  Hideyuki Muranaka; Takaki Momose; Chiaki Handa; Tomonaga Ozawa
Journal:  ACS Med Chem Lett       Date:  2017-05-17       Impact factor: 4.345

Review 3.  Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

Authors:  Rajashri Sridharan; Jeffrey Zuber; Sara M Connelly; Elizabeth Mathew; Mark E Dumont
Journal:  Biochim Biophys Acta       Date:  2013-09-18

4.  Synthesis of BODIPY derivatives substituted with various bioconjugatable linker groups: a construction kit for fluorescent labeling of receptor ligands.

Authors:  Fabian Heisig; Sabrina Gollos; Sven J Freudenthal; Ali El-Tayeb; Jamshed Iqbal; Christa E Müller
Journal:  J Fluoresc       Date:  2013-09-20       Impact factor: 2.217

5.  GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonists.

Authors:  Angela Kecskés; Dilip K Tosh; Qiang Wei; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2011-05-12       Impact factor: 4.774

Review 6.  Fluorescent ligands for adenosine receptors.

Authors:  Eszter Kozma; P Suresh Jayasekara; Lucia Squarcialupi; Silvia Paoletta; Stefano Moro; Stephanie Federico; Giampiero Spalluto; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2012-11-05       Impact factor: 2.823

7.  Modulation of G protein-coupled adenosine receptors by strategically functionalized agonists and antagonists immobilized on gold nanoparticles.

Authors:  P Suresh Jayasekara; Khai Phan; Dilip K Tosh; T Santhosh Kumar; Steven M Moss; Guofeng Zhang; Joseph J Barchi; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2012-11-20       Impact factor: 3.765

8.  6-(4-Chloro-phen-yl)-2-(4-meth-oxy-phen-yl)-6,7-dihydro-4H-pyrazolo-[5,1-c][1,4]oxazine.

Authors:  Liang-Wen Zheng; Bao-Xiang Zhao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-09

9.  Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congeners.

Authors:  Romain Duroux; Antonella Ciancetta; Philip Mannes; Jinha Yu; Shireesha Boyapati; Elizabeth Gizewski; Said Yous; Francisco Ciruela; John A Auchampach; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2017-06-22       Impact factor: 3.597

Review 10.  Chemical Probes for the Adenosine Receptors.

Authors:  Stephanie Federico; Lucia Lassiani; Giampiero Spalluto
Journal:  Pharmaceuticals (Basel)       Date:  2019-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.